A team at MIT developed COMET, an AI-powered platform utilizing transformer neural networks to design lipid nanoparticles that improve RNA delivery efficacy across various cell types. Published in Nature Nanotechnology, their method accelerates nanoparticle optimization for vaccines and RNA therapeutics, promising enhanced treatments for obesity, diabetes, and other conditions. This computational approach aids rapid identification of materials with superior protein expression in vivo and in vitro.